Càndid Villanueva

机构：Hospital de Sant Pau, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ORCID：0000-0002-3674-914X

发表论文 210 篇 · 总被引 16732 次 · h-index 52

代表论文

• Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome (2024 · Journal of Hepatology · 被引 52)
• Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial (2024 · Journal of Hepatology · 被引 31)
• Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis (2024 · Journal of Hepatology · 被引 29)
• Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized trial (2024 · Hepatology · 被引 17)
• Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study (2025 · Journal of Hepatology · 被引 11)
• Progressive systemic inflammation precedes decompensation in compensated cirrhosis (2024 · JHEP Reports · 被引 8)